Ipsen, a €1.2 billion specialty pharmaceutical company with solid presence in neurology, endocrinology and uro-oncology, recently announced a decision to redeploy its US sales strategy. How should this announcement be perceived? Leading French-language life sciences...
The Triana Group announces the completion of a proprietary Need Analysis and Market Demand Study for specialized robotics applications in the fields of logistics and retail. The study’s insights have informed clients at C-level about market potential for...
A European Commission-sponsored program called bioXclusters selected The Triana Group Advisor and CEO of Taku Group Dr. Karin Hollerbach, as its US Life Sciences expert for a series of seminars to be held in four European countries. Following The Triana Group’s...
Hosted by the world’s leading trade publication in the French language Biotech Finances, this webinar was held in English by Lorraine Marchand and Omar Mencin. It is suitable for overseas as well as American early-stage companies seeking an overview of US...
The Triana Group announces completion of a several-month proprietary market study of the United States Photonics sector. The study focuses on a specific cluster in the North-East of the United States within the context of the larger national and global market. It...
The Triana Group announces completion of a proprietary study on maritime technologies. The proprietary report is based on substantial qualitative and quantitative data analysis, in-depth expert interviews, a two-day workshop with multiple maritime technology...